Potential synergistic effects of bisphosphonates with sorafenib on renal cell carcinoma with bone metastases
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Sorafenib (Primary) ; Clodronic acid; Zoledronic acid
- Indications Bone metastases; Renal cell carcinoma
- Focus Therapeutic Use
- 17 Aug 2015 New trial record